Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial-Reference-Cited by-同舟云学术

Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial

Published:2016-09 Issue:1 Volume:1 Page:36-44
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Waked Imam,Shiha Gamal,Qaqish Roula B,Esmat Gamal,Yosry Ayman,Hassany Mohamed,Soliman Reham,Mohey Mohammad A,Allam Naglaa,Zayed Naglaa,Asselah Tarik,Hall Coleen,Redman Rebecca,Mobashery Niloufar,Doss Wahid

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Global distribution and prevalence of hepatitis C virus genotypes;Messina;Hepatology,2015

2. The current and future disease burden of chronic hepatitis C virus infection in Egypt;Waked;Arab J Gastroenterol,2014

3. Global epidemiology and genotype distribution of the hepatitis C virus infection;Gower;J Hepatol,2014

4. Historical epidemiology of hepatitis C virus (HCV) in selected countries;Bruggmann;J Viral Hepat,2014

5. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt;Sievert;Liver Int,2011

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Elimination in Egypt: Story of Success;Pathogens;2024-08-12

2. New incidence or recurrence hepatocellular carcinoma (HCC) in genotype 4 hepatitis C virus treated with sofosbuvir/daclatasvir with or without ribavirin;F1000Research;2024-07-03

3. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals;Expert Opinion on Pharmacotherapy;2024-05-02

4. Efficacy of combined antiretroviral therapy (cART) in Hepatitis B and C associated hepatocellular carcinoma (HCC): a narrative review;Journal of Human Virology & Retrovirology;2023-12-29

5. Comparative Real Life Egyptian Experience of the Combination of Sofosbuvir Plus Daclatasvir or Simeprevir for 12 Weeks in Naïve Cirrhotic Patients Infected with HCV Genotype 4;Current Drug Safety;2023-05